Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

46 (2%)

Anticipated shortage:

1 (0%)

Avoided shortage:

19 (1%)

Resolved:

2226 (97%)

2292

Discontinuation Reports

To be discontinued:

4 (3%)

Discontinued:

119 (95%)

Reversed:

2 (2%)

125

453 (19%)

18 (35%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ FENTANYL PATCH 12MCG PATCH Resolved 2020-07-02 2020-07-20 119340
SANDOZ FENTANYL PATCH 100MCG PATCH Resolved 2021-11-08 2022-01-12 148967
SANDOZ FENTANYL PATCH 37MCG PATCH Resolved 2021-09-02 2021-09-09 145007
SANDOZ FESOTERODINE FUMARATE 4MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-03 2025-02-17 249417
SANDOZ FESOTERODINE FUMARATE 8MG TABLET (EXTENDED-RELEASE) Resolved 2024-09-16 2024-12-24 237761
SANDOZ FESOTERODINE FUMARATE 8MG TABLET (EXTENDED-RELEASE) Resolved 2024-11-11 2024-12-17 242755
SANDOZ FESOTERODINE FUMARATE 4MG TABLET (EXTENDED-RELEASE) Resolved 2024-11-25 2024-12-17 243846
SANDOZ FESOTERODINE FUMARATE 4MG TABLET (EXTENDED-RELEASE) Resolved 2025-06-23 2025-08-12 260887
SANDOZ FESOTERODINE FUMARATE 8MG TABLET (EXTENDED-RELEASE) Resolved 2025-10-27 2026-01-08 270362
SANDOZ FESOTERODINE FUMARATE 4MG TABLET (EXTENDED-RELEASE) Resolved 2025-10-27 2025-11-03 270352
SANDOZ FESOTERODINE FUMARATE 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-28 2022-12-28 175986
SANDOZ FESOTERODINE FUMARATE 8MG TABLET (EXTENDED-RELEASE) Resolved 2024-08-27 2024-09-09 236045
SANDOZ FESOTERODINE FUMARATE 4MG TABLET (EXTENDED-RELEASE) Resolved 2024-07-15 2024-09-04 232903
SANDOZ FINASTERIDE 5MG TABLET Resolved 2025-01-13 2025-04-02 247627
SANDOZ FINASTERIDE 5MG TABLET Resolved 2022-11-02 2023-04-12 173375
SANDOZ FINASTERIDE 5MG TABLET Resolved 2019-07-16 2021-03-08 89384
SANDOZ FINASTERIDE 5MG TABLET Resolved 2024-07-08 2024-12-11 232483
SANDOZ FINASTERIDE 5MG TABLET Resolved 2020-08-31 2021-03-08 123416
SANDOZ FINASTERIDE 5MG TABLET Resolved 2019-11-18 2020-08-24 99069
SANDOZ FINASTERIDE 5MG TABLET Resolved 2017-06-26 2017-09-07 13929
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000

Showing 1 to 20 of 125